PRECIGEN INC (PGEN) Fundamental Analysis & Valuation

NASDAQ:PGEN • US74017N1054

Current stock price

4.16 USD
-0.11 (-2.58%)
At close:
4.11 USD
-0.05 (-1.2%)
After Hours:

This PGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PGEN Profitability Analysis

1.1 Basic Checks

  • PGEN had negative earnings in the past year.
  • PGEN had a negative operating cash flow in the past year.
  • In the past 5 years PGEN reported 4 times negative net income.
  • In the past 5 years PGEN always reported negative operating cash flow.
PGEN Yearly Net Income VS EBIT VS OCF VS FCFPGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M -500M

1.2 Ratios

  • PGEN has a Return On Assets of -276.29%. This is amonst the worse of the industry: PGEN underperforms 91.68% of its industry peers.
  • With a Return On Equity value of -2054.62%, PGEN is not doing good in the industry: 82.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -276.29%
ROE -2054.62%
ROIC N/A
ROA(3y)-142.23%
ROA(5y)-87.84%
ROE(3y)-774.91%
ROE(5y)-477.65%
ROIC(3y)N/A
ROIC(5y)N/A
PGEN Yearly ROA, ROE, ROICPGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

  • PGEN's Gross Margin of 50.20% is fine compared to the rest of the industry. PGEN outperforms 74.66% of its industry peers.
  • PGEN's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PGEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y1.66%
PGEN Yearly Profit, Operating, Gross MarginsPGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PGEN Health Analysis

2.1 Basic Checks

  • PGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PGEN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PGEN has more shares outstanding
  • Compared to 1 year ago, PGEN has a worse debt to assets ratio.
PGEN Yearly Shares OutstandingPGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
PGEN Yearly Total Debt VS Total AssetsPGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -16.11, we must say that PGEN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -16.11, PGEN is not doing good in the industry: 81.43% of the companies in the same industry are doing better.
  • PGEN has a Debt/Equity ratio of 4.46. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of PGEN (4.46) is worse than 81.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.46
Debt/FCF N/A
Altman-Z -16.11
ROIC/WACCN/A
WACC9.21%
PGEN Yearly LT Debt VS Equity VS FCFPGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • PGEN has a Current Ratio of 3.09. This indicates that PGEN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.09, PGEN is doing worse than 62.09% of the companies in the same industry.
  • PGEN has a Quick Ratio of 2.83. This indicates that PGEN is financially healthy and has no problem in meeting its short term obligations.
  • PGEN's Quick ratio of 2.83 is on the low side compared to the rest of the industry. PGEN is outperformed by 62.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 2.83
PGEN Yearly Current Assets VS Current LiabilitesPGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. PGEN Growth Analysis

3.1 Past

  • The earnings per share for PGEN have decreased strongly by -268.57% in the last year.
  • Looking at the last year, PGEN shows a very strong growth in Revenue. The Revenue has grown by 146.73%.
  • PGEN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -37.70% yearly.
EPS 1Y (TTM)-268.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)146.73%
Revenue growth 3Y-28.86%
Revenue growth 5Y-37.7%
Sales Q2Q%283.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.29% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, PGEN will show a very strong growth in Revenue. The Revenue will grow by 103.93% on average per year.
EPS Next Y96.31%
EPS Next 2Y45.56%
EPS Next 3Y32.91%
EPS Next 5Y21.29%
Revenue Next Year577.54%
Revenue Next 2Y250.24%
Revenue Next 3Y165.76%
Revenue Next 5Y103.93%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PGEN Yearly Revenue VS EstimatesPGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
PGEN Yearly EPS VS EstimatesPGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. PGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • PGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PGEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PGEN Price Earnings VS Forward Price EarningsPGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PGEN Per share dataPGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

  • PGEN's earnings are expected to grow with 32.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.56%
EPS Next 3Y32.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PGEN Dividend Analysis

5.1 Amount

  • PGEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PGEN Fundamentals: All Metrics, Ratios and Statistics

PRECIGEN INC

NASDAQ:PGEN (4/10/2026, 8:00:01 PM)

After market: 4.11 -0.05 (-1.2%)

4.16

-0.11 (-2.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners73.14%
Inst Owner Change0.02%
Ins Owners2.98%
Ins Owner Change2.64%
Market Cap1.47B
Revenue(TTM)9.68M
Net Income(TTM)-429.64M
Analysts80
Price Target9.69 (132.93%)
Short Float %13.02%
Short Ratio8.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-488.13%
Min EPS beat(2)-993.91%
Max EPS beat(2)17.64%
EPS beat(4)2
Avg EPS beat(4)-242.2%
Min EPS beat(4)-993.91%
Max EPS beat(4)17.64%
EPS beat(8)2
Avg EPS beat(8)-124.58%
EPS beat(12)3
Avg EPS beat(12)-87.29%
EPS beat(16)5
Avg EPS beat(16)-83.4%
Revenue beat(2)1
Avg Revenue beat(2)213.48%
Min Revenue beat(2)-45.98%
Max Revenue beat(2)472.94%
Revenue beat(4)3
Avg Revenue beat(4)153.95%
Min Revenue beat(4)-45.98%
Max Revenue beat(4)472.94%
Revenue beat(8)3
Avg Revenue beat(8)62.8%
Revenue beat(12)3
Avg Revenue beat(12)33.54%
Revenue beat(16)3
Avg Revenue beat(16)6.97%
PT rev (1m)11.76%
PT rev (3m)11.76%
EPS NQ rev (1m)57.33%
EPS NQ rev (3m)57.33%
EPS NY rev (1m)74.07%
EPS NY rev (3m)73.58%
Revenue NQ rev (1m)-13.33%
Revenue NQ rev (3m)-13.33%
Revenue NY rev (1m)17.13%
Revenue NY rev (3m)17.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 152.04
P/FCF N/A
P/OCF N/A
P/B 70.41
P/tB 589.65
EV/EBITDA N/A
EPS(TTM)-1.29
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.03
BVpS0.06
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -276.29%
ROE -2054.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.2%
FCFM N/A
ROA(3y)-142.23%
ROA(5y)-87.84%
ROE(3y)-774.91%
ROE(5y)-477.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y1.66%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.36%
Cap/Sales 20.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 2.83
Altman-Z -16.11
F-Score4
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)91.69%
Cap/Depr(5y)74.69%
Cap/Sales(3y)87.99%
Cap/Sales(5y)66.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-268.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y96.31%
EPS Next 2Y45.56%
EPS Next 3Y32.91%
EPS Next 5Y21.29%
Revenue 1Y (TTM)146.73%
Revenue growth 3Y-28.86%
Revenue growth 5Y-37.7%
Sales Q2Q%283.61%
Revenue Next Year577.54%
Revenue Next 2Y250.24%
Revenue Next 3Y165.76%
Revenue Next 5Y103.93%
EBIT growth 1Y-12.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.84%
OCF growth 3YN/A
OCF growth 5YN/A

PRECIGEN INC / PGEN Fundamental Analysis FAQ

What is the fundamental rating for PGEN stock?

ChartMill assigns a fundamental rating of 2 / 10 to PGEN.


Can you provide the valuation status for PRECIGEN INC?

ChartMill assigns a valuation rating of 1 / 10 to PRECIGEN INC (PGEN). This can be considered as Overvalued.


How profitable is PRECIGEN INC (PGEN) stock?

PRECIGEN INC (PGEN) has a profitability rating of 1 / 10.